Best Tablet Ginkgo Biloba Supplier & Factory

Standard native Ginkgo Biloba powder is characterized by fine particle size, irregular morphology, poor bulk density (0.25-0.35 g/mL), high static charges, and strong hygroscopicity, which causes capping, sticking, and die-fill weight variations when compressed on high-speed rotary presses. Our DC-grade Ginkgo Biloba granules are engineered through fluidized-bed agglomeration with pharmaceutical-grade binders (such as SMCC, isomalt, or povidone), creating spherical granules with high flowability (Carr’s Index < 18%), bulk density (0.50-0.60 g/mL), and immediate mechanical compressibility without pre-blending difficulties.

Economic adulteration of Ginkgo Biloba is prevalent in low-cost supply chains where synthetic or unapproved botanical flavonoids are added to artificially inflate the 24% spectrophotometric or standard HPLC assay. Our analytical laboratory executes USP and Ph. Eur. peak-ratio chromatography. Authenticated Ginkgo biloba leaf extract possesses a strict natural stoichiometric ratio: the peak area ratio of quercetin to kaempferol must be between 0.8 and 1.2, and isorhamnetin must represent not less than 4.0% of the total flavonol area. Furthermore, unhydrolyzed extracts are screened via HPLC to confirm the complete absence of free rutin and sophoricoside peaks.

Ginkgolic acids (alkylphenols including ginkgolic acid C13:0, C15:1, and C17:1) are known to cause severe allergic contact dermatitis, cytotoxicity, genotoxicity, and immunotoxicity. International regulatory bodies (including the US FDA, European Medicines Agency, and Chinese Pharmacopoeia) mandate that the ginkgolic acid content in commercial preparations must not exceed 5.0 ppm (5 mcg/g). For pharmaceutical-grade hospital contracts and sensitive patient formulations, our specialized multi-step polymeric resin adsorption drops residual ginkgolic acids to < 1.0 ppm, as validated by high-resolution LC-MS/MS.

We offer full turn-key OEM/ODM custom tableting services. Physical tablet configurations include round (6 mm to 12 mm), oval, modified capsule-shape (caplets), bilayer extended-release tablets, and chewable formats. Surface finishing ranges from clear natural botanical coatings to color-coded HPMC moisture-barrier films or plant-based chlorophyll enteric coatings. Finished packaging formats include bulk cartons (double polyethylene bags), HDPE bottles with induction foil seals, and pharmaceutical Alu-Alu / PVC-PVDC blister packaging.

For bulk direct-compressible (DC) standardized Ginkgo Biloba extract granules, our standard MOQ is 25 kg (fiber drum with inner heat-sealed PE bag). For custom manufactured finished tablets, our standard MOQ is 300,000 tablets for custom tooling/shape orders, or 100,000 tablets for standard existing round/caplet molds. Standard sample dispatch takes 24-48 hours with complete analytical COAs; full commercial manufacturing lead times range between 3 to 4 weeks upon pilot batch approval.